Characterization of iron(II).cntdot.bleomycin-mediated RNA strand scission

Citations Over TimeTop 10% of 1993 papers

Abstract

The ability of iron(II).bleomycin to mediate RNA degradation was further characterized. At micromolar concentrations, FeII.BLM was shown to effect cleavage of Escherichia coli tRNA(1His) and a Schizosaccharomyces pombe amber suppressor tRNA construct in an efficient fashion. In contrast, E. coli tRNA(Cys) and yeast mitochondrial tRNA(Asp) and tRNA(fMet) precursors were not substrates for FeII.BLM. Also shown to be a good substrate for cleavage by FeII.BLM was yeast 5S ribosomal RNA. Since HIV-1 reverse transcriptase mRNA has previously been shown to be degraded by Fe.BLM (Carter et al., 1990a), members of the three major classes of RNA have now been shown to undergo Fe.BLM-mediated strand scission. For each of the substrate RNAs, cleavage occurred at sites unique to that substrate. Although RNA cleavage occurred at numerous sequences, 5'-G-pyr-3' sites were prominent. Likewise, while cleavage was noted in regions anticipated to be double-stranded, as well as in single-stranded regions, a disproportionate number of cleavages were noted at the junction between single- and double-stranded regions. As found in earlier studies, RNA cleavage was much more selective than DNA cleavage. Further, when RNA cleavage was carried out in the presence of reagents such as Mg2+, spermidine, and NaCl, the selectivity of cleavage was further enhanced. The highly selective and efficient cleavage of a number of RNA molecules reinforces our earlier suggestion that RNA may constitute a therapeutically relevant target for bleomycin.

Related Papers

• → BLEOMYCIN: AN EFFECTIVE TREATMENT FOR WARTS(1979)36 cited
• → The effect of endotoxin on bleomycin-induced lung fibrosis in the rat(1985)10 cited
• Development and time-course of bleomycin-induced pulmonary fibrosis in NMRI mice(2007)
• → HYPERTHERMIC THERAPY OF THE BLADDER CANCER(1981)2 cited
• → P105 <break /> Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity(2016)